Sittner & Nelson LLC Buys 1,158 Shares of CVS Health Co. (NYSE:CVS)

Sittner & Nelson LLC raised its stake in shares of CVS Health Co. (NYSE:CVS) by 152.4% in the 3rd quarter, Holdings Channel reports. The firm owned 1,918 shares of the pharmacy operator’s stock after purchasing an additional 1,158 shares during the quarter. Sittner & Nelson LLC’s holdings in CVS Health were worth $121,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Cullinan Associates Inc. raised its position in CVS Health by 43.8% during the 3rd quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock worth $7,125,000 after purchasing an additional 37,395 shares during the last quarter. Deerfield Management Company L.P. Series C acquired a new stake in CVS Health during the 2nd quarter worth about $57,584,000. CX Institutional grew its holdings in CVS Health by 698.0% during the 3rd quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock worth $4,691,000 after acquiring an additional 65,259 shares during the period. Susquehanna Fundamental Investments LLC grew its holdings in CVS Health by 27.9% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock worth $39,302,000 after acquiring an additional 145,158 shares during the period. Finally, AustralianSuper Pty Ltd grew its holdings in CVS Health by 11.0% during the 3rd quarter. AustralianSuper Pty Ltd now owns 1,537,791 shares of the pharmacy operator’s stock worth $96,696,000 after acquiring an additional 151,901 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Price Performance

CVS stock opened at $57.11 on Friday. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The business has a 50-day simple moving average of $59.59 and a two-hundred day simple moving average of $59.23. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The company has a market capitalization of $71.84 billion, a P/E ratio of 14.49, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter last year, the firm earned $2.21 EPS. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. Research analysts expect that CVS Health Co. will post 6.27 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. CVS Health’s dividend payout ratio is currently 67.51%.

Analyst Ratings Changes

CVS has been the subject of a number of recent analyst reports. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday. Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Finally, Barclays reduced their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $73.00.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.